|
RAB23 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.854020E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.082390E-02 |
| Normal-vs-Stage2 |
3.024400E-02 |
| Normal-vs-Stage3 |
2.990800E-01 |
| Normal-vs-Stage4 |
1.953220E-01 |
| Stage1-vs-Stage2 |
7.977800E-01 |
| Stage1-vs-Stage3 |
1.290420E-01 |
| Stage1-vs-Stage4 |
3.868400E-01 |
| Stage2-vs-Stage3 |
1.855170E-01 |
| Stage2-vs-Stage4 |
3.855800E-01 |
| Stage3-vs-Stage4 |
7.192800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.019500E-02 |
| Normal-vs-AfricanAmerican |
4.779800E-02 |
| Normal-vs-Asian |
8.822200E-01 |
| Caucasian-vs-AfricanAmerican |
4.903800E-01 |
| Caucasian-vs-Asian |
3.100200E-01 |
| AfricanAmerican-vs-Asian |
3.069800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.116200E-02 |
| Normal-vs-Female |
5.103800E-03 |
| Male-vs-Female |
5.484300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.671600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.223010E-01 |
| Normal-vs-Age(61-80Yrs) |
7.756100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.337640E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.118000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.681600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.232500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.010950E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.020290E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.765240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.468470E-02 |
| Normal-vs-Grade 2 |
3.148000E-02 |
| Normal-vs-Grade 3 |
3.260400E-02 |
| Normal-vs-Grade 4 |
2.576200E-01 |
| Grade 1-vs-Grade 2 |
3.344200E-01 |
| Grade 1-vs-Grade 3 |
2.161800E-01 |
| Grade 1-vs-Grade 4 |
1.226800E-01 |
| Grade 2-vs-Grade 3 |
8.368800E-01 |
| Grade 2-vs-Grade 4 |
5.351800E-01 |
| Grade 3-vs-Grade 4 |
4.743400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.797600E-03 |
| Normal-vs-ccB subtype |
7.952800E-01 |
| ccA subtype-vs-ccB subtype |
7.597700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.413700E-02 |
| Normal-vs-N1 |
3.687400E-01 |
| N0-vs-N1 |
9.489000E-01 |
|
|
